ABCD4
Basic information
Region (hg38): 14:74285269-74303055
Previous symbols: [ "PXMP1L" ]
Links
Phenotypes
GenCC
Source:
- methylmalonic acidemia with homocystinuria, type cblJ (Strong), mode of inheritance: AR
- methylmalonic acidemia with homocystinuria, type cblJ (Strong), mode of inheritance: AR
- methylmalonic acidemia with homocystinuria, type cblJ (Supportive), mode of inheritance: AR
- methylmalonic acidemia with homocystinuria, type cblJ (Moderate), mode of inheritance: AR
- methylmalonic acidemia with homocystinuria, type cblJ (Moderate), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Methylmalonic aciduria and homocystinuria, cblJ type | AR | Allergy/Immunology/Infectious; Biochemical; Cardiovascular | Administration of hydroxocobalamin/methylcobalamin has been described as beneficial; Due to infectious risks, administration of G-CSF has been described, and early and aggressive treatment of infections may be benefiical; Surveillance for cardiovascular manifestations may allow early management | Allergy/Immunology/Infectious; Biochemical; Cardiovascular; Neurologic | 22922874; 23141461 |
ClinVar
This is a list of variants' phenotypes submitted to
- Methylmalonic acidemia with homocystinuria, type cblJ (10 variants)
- Cobalamin C disease (2 variants)
- not provided (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ABCD4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 67 | 77 | ||||
missense | 122 | 16 | 144 | |||
nonsense | 4 | |||||
start loss | 1 | |||||
frameshift | 10 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 7 | |||||
splice region | 8 | 15 | 5 | 28 | ||
non coding | 69 | 71 | 142 | |||
Total | 12 | 7 | 132 | 152 | 82 |
Highest pathogenic variant AF is 0.0000197
Variants in ABCD4
This is a list of pathogenic ClinVar variants found in the ABCD4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-74286199-A-C | Benign (Jul 31, 2018) | |||
14-74286273-G-A | Benign (Feb 08, 2019) | |||
14-74286341-T-C | Benign (Jul 26, 2019) | |||
14-74286404-C-G | Benign (Feb 08, 2019) | |||
14-74286409-C-T | Benign (May 06, 2019) | |||
14-74286438-C-T | Benign (Feb 08, 2019) | |||
14-74286456-G-A | not specified | Likely benign (Aug 11, 2016) | ||
14-74286464-T-C | Methylmalonic acidemia with homocystinuria, type cblJ | Likely benign (Apr 28, 2021) | ||
14-74286468-A-G | Inborn genetic diseases | Uncertain significance (Dec 11, 2023) | ||
14-74286477-C-G | Methylmalonic acidemia with homocystinuria, type cblJ | Uncertain significance (Sep 13, 2022) | ||
14-74286488-C-G | Methylmalonic acidemia with homocystinuria, type cblJ | Uncertain significance (Apr 01, 2020) | ||
14-74286501-CCA-C | not specified | Uncertain significance (Mar 09, 2022) | ||
14-74286508-G-A | Methylmalonic acidemia with homocystinuria, type cblJ | Uncertain significance (Oct 05, 2022) | ||
14-74286526-G-C | Inborn genetic diseases | Uncertain significance (Jan 12, 2021) | ||
14-74286533-C-T | not specified • Methylmalonic acidemia with homocystinuria, type cblJ | Likely benign (Jun 13, 2022) | ||
14-74286541-C-T | Uncertain significance (Aug 01, 2021) | |||
14-74286547-C-T | not specified • Methylmalonic acidemia with homocystinuria, type cblJ | Conflicting classifications of pathogenicity (Jan 17, 2022) | ||
14-74286575-T-C | Methylmalonic acidemia with homocystinuria, type cblJ | Benign (Jul 14, 2021) | ||
14-74286660-G-A | Benign (Jun 23, 2018) | |||
14-74286694-C-T | Methylmalonic acidemia with homocystinuria, type cblJ | Likely benign (Nov 09, 2021) | ||
14-74286696-G-A | not specified • Methylmalonic acidemia with homocystinuria, type cblJ • ABCD4-related disorder | Benign (Jan 18, 2024) | ||
14-74286699-A-G | Methylmalonic acidemia with homocystinuria, type cblJ | Uncertain significance (Aug 13, 2021) | ||
14-74286706-C-CAG | Methylmalonic acidemia with homocystinuria, type cblJ | Pathogenic (Oct 01, 2012) | ||
14-74286710-G-C | Methylmalonic acidemia with homocystinuria, type cblJ | Uncertain significance (Jun 13, 2022) | ||
14-74286713-C-G | Inborn genetic diseases | Uncertain significance (Jan 07, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ABCD4 | protein_coding | protein_coding | ENST00000356924 | 19 | 17634 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.34e-12 | 0.921 | 125672 | 0 | 76 | 125748 | 0.000302 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.169 | 347 | 356 | 0.975 | 0.0000211 | 3926 |
Missense in Polyphen | 99 | 111.19 | 0.89039 | 1225 | ||
Synonymous | -0.725 | 162 | 151 | 1.08 | 0.00000942 | 1200 |
Loss of Function | 2.06 | 25 | 38.9 | 0.643 | 0.00000203 | 408 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000456 | 0.000456 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000544 | 0.000544 |
Finnish | 0.000186 | 0.000185 |
European (Non-Finnish) | 0.000381 | 0.000378 |
Middle Eastern | 0.000544 | 0.000544 |
South Asian | 0.000165 | 0.000163 |
Other | 0.000816 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in intracellular processing of vitamin B12 (cobalamin). Could play a role in the lysosomal release of vitamin B12 into the cytoplasm. {ECO:0000269|PubMed:22922874}.;
- Pathway
- Peroxisome - Homo sapiens (human);ABC transporters - Homo sapiens (human);Cobalamin (Cbl, vitamin B12) transport and metabolism;Metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
(Consensus)
Recessive Scores
- pRec
- 0.153
Intolerance Scores
- loftool
- 0.152
- rvis_EVS
- 0.8
- rvis_percentile_EVS
- 87.72
Haploinsufficiency Scores
- pHI
- 0.141
- hipred
- N
- hipred_score
- 0.289
- ghis
- 0.489
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.413
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Abcd4
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- cobalamin metabolic process;transmembrane transport;cellular response to leukemia inhibitory factor
- Cellular component
- lysosomal membrane;peroxisome;peroxisomal membrane;endoplasmic reticulum membrane;integral component of membrane;ATP-binding cassette (ABC) transporter complex
- Molecular function
- ATP binding;ATPase activity, coupled to transmembrane movement of substances